APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Pathology Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digital Pathology Solutions Market Outlook and Growth Opportunities 2026

1 January 2026202 pages

Choose your research edition.

Industry ResearchDigital Pathology Solutions Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Pathology Solutions Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Digital Pathology Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Pathology Solutions Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Pathology Solutions Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Digital Pathology Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digital Pathology Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digital Pathology Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Pathology Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digital Pathology Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digital Pathology Solutions market include Roche Diagnostics, Proscia, 3DHISTECH Ltd., Philips, Siemens, Morphle Labs Inc, TriStar Technology Group, Iron Mountain and Smart In Media AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Digital Pathology Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digital Pathology Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digital Pathology Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digital Pathology Solutions market.

Digital Pathology Solutions Segment by Company

Roche Diagnostics

Proscia

3DHISTECH Ltd.

Philips

Siemens

Morphle Labs Inc

TriStar Technology Group

Iron Mountain

Smart In Media AG

HealthTrust Europe

Dedalus

Tribun Health

Qube scientific

Leica Biosystems

Schneider Electric

PathGroup

Sectra

Gestalt Diagnostics

Charles River Laboratories

Digital Pathology Solutions Segment by Type

Cytopathology

Histopathology

Digital Pathology Solutions Segment by Application

Pathological Diagnosis

Clinical Laboratory

Drug Discovery

Others

Digital Pathology Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Digital Pathology Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Digital Pathology Solutions key companies, revenue, market share, and recent developments.

3. To split the Digital Pathology Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Digital Pathology Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digital Pathology Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Digital Pathology Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Pathology Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Pathology Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Pathology Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Pathology Solutions industry.

Chapter 3: Detailed analysis of Digital Pathology Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Digital Pathology Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Digital Pathology Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digital Pathology Solutions Industry Trends Table 2. Digital Pathology Solutions Industry Drivers Table 3. Digital Pathology Solutions Industry Opportunities and Challenges Table 4. Digital Pathology Solutions Industry Restraints Table 5. Global Digital Pathology Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digital Pathology Solutions Revenue Share by Company (2021-2026) Table 7. Global Digital Pathology Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Digital Pathology Solutions Key Company Manufacturing Base & Headquarters Table 9. Global Digital Pathology Solutions Company, Product Type & Application Table 10. Global Digital Pathology Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Digital Pathology Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cytopathology Table 15. Significant Companies of Histopathology Table 16. Global Digital Pathology Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Digital Pathology Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Digital Pathology Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Digital Pathology Solutions Sales Value Share by Type (2021-2026) Table 20. Global Digital Pathology Solutions Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pathological Diagnosis Table 22. Significant Companies of Clinical Laboratory Table 23. Significant Companies of Drug Discovery Table 24. Significant Companies of Others Table 25. Global Digital Pathology Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Digital Pathology Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Digital Pathology Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Digital Pathology Solutions Sales Value Share by Application (2021-2026) Table 29. Global Digital Pathology Solutions Sales Value Share by Application (2027-2032) Table 30. Global Digital Pathology Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Digital Pathology Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Digital Pathology Solutions Sales Value Share by Region (2021-2026) Table 33. Global Digital Pathology Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Digital Pathology Solutions Sales Value Share by Region (2027-2032) Table 35. Global Digital Pathology Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Digital Pathology Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Digital Pathology Solutions Sales Value Market Share by Country (2021-2026) Table 38. Global Digital Pathology Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Digital Pathology Solutions Sales Value Market Share by Country (2027-2032) Table 40. Roche Diagnostics Company Information Table 41. Roche Diagnostics Business Overview Table 42. Roche Diagnostics Digital Pathology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Roche Diagnostics Digital Pathology Solutions Product Portfolio Table 44. Roche Diagnostics Recent Development Table 45. Proscia Company Information Table 46. Proscia Business Overview Table 47. Proscia Digital Pathology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Proscia Digital Pathology Solutions Product Portfolio Table 49. Proscia Recent Development Table 50. 3DHISTECH Ltd. Company Information Table 51. 3DHISTECH Ltd. Business Overview Table 52. 3DHISTECH Ltd. Digital Pathology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. 3DHISTECH Ltd. Digital Pathology Solutions Product Portfolio Table 54. 3DHISTECH Ltd. Recent Development Table 55. Philips Company Information Table 56. Philips Business Overview Table 57. Philips Digital Pathology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Philips Digital Pathology Solutions Product Portfolio Table 59. Philips Recent Development Table 60. Siemens Company Information Table 61. Siemens Business Overview Table 62. Siemens Digital Pathology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Siemens Digital Pathology Solutions Product Portfolio Table 64. Siemens Recent Development Table 65. Morphle Labs Inc Company Information Table 66. Morphle Labs Inc Business Overview Table 67. Morphle Labs Inc Digital Pathology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Morphle Labs Inc Digital Pathology Solutions Product Portfolio Table 69. Morphle Labs Inc Recent Development Table 70. TriStar Technology Group Company Information Table 71. TriStar Technology Group Business Overview Table 72. TriStar Technology Group Digital Pathology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. TriStar Technology Group Digital Pathology Solutions Product Portfolio Table 74. TriStar Technology Group Recent Development Table 75. Iron Mountain Company Information Table 76. Iron Mountain Business Overview Table 77. Iron Mountain Digital Pathology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Iron Mountain Digital Pathology Solutions Product Portfolio Table 79. Iron Mountain Recent Development Table 80. Smart In Media AG Company Information Table 81. Smart In Media AG Business Overview Table 82. Smart In Media AG Digital Pathology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Smart In Media AG Digital Pathology Solutions Product Portfolio Table 84. Smart In Media AG Recent Development Table 85. HealthTrust Europe Company Information Table 86. HealthTrust Europe Business Overview Table 87. HealthTrust Europe Digital Pathology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. HealthTrust Europe Digital Pathology Solutions Product Portfolio Table 89. HealthTrust Europe Recent Development Table 90. Dedalus Company Information Table 91. Dedalus Business Overview Table 92. Dedalus Digital Pathology Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Dedalus Digital Pathology Solutions Product Portfolio Table 94. Dedalus Recent Development Table 95. Tribun Health Company Information Table 96. Tribun Health Business Overview Table 97. Tribun Health Digital Pathology Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Tribun Health Digital Pathology Solutions Product Portfolio Table 99. Tribun Health Recent Development Table 100. Qube scientific Company Information Table 101. Qube scientific Business Overview Table 102. Qube scientific Digital Pathology Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Qube scientific Digital Pathology Solutions Product Portfolio Table 104. Qube scientific Recent Development Table 105. Leica Biosystems Company Information Table 106. Leica Biosystems Business Overview Table 107. Leica Biosystems Digital Pathology Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Leica Biosystems Digital Pathology Solutions Product Portfolio Table 109. Leica Biosystems Recent Development Table 110. Schneider Electric Company Information Table 111. Schneider Electric Business Overview Table 112. Schneider Electric Digital Pathology Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Schneider Electric Digital Pathology Solutions Product Portfolio Table 114. Schneider Electric Recent Development Table 115. PathGroup Company Information Table 116. PathGroup Business Overview Table 117. PathGroup Digital Pathology Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. PathGroup Digital Pathology Solutions Product Portfolio Table 119. PathGroup Recent Development Table 120. Sectra Company Information Table 121. Sectra Business Overview Table 122. Sectra Digital Pathology Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Sectra Digital Pathology Solutions Product Portfolio Table 124. Sectra Recent Development Table 125. Gestalt Diagnostics Company Information Table 126. Gestalt Diagnostics Business Overview Table 127. Gestalt Diagnostics Digital Pathology Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Gestalt Diagnostics Digital Pathology Solutions Product Portfolio Table 129. Gestalt Diagnostics Recent Development Table 130. Charles River Laboratories Company Information Table 131. Charles River Laboratories Business Overview Table 132. Charles River Laboratories Digital Pathology Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Charles River Laboratories Digital Pathology Solutions Product Portfolio Table 134. Charles River Laboratories Recent Development Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Digital Pathology Solutions Product Image Figure 2. Global Digital Pathology Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Pathology Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Digital Pathology Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cytopathology Image Figure 8. Histopathology Image Figure 9. Global Digital Pathology Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Digital Pathology Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Digital Pathology Solutions Sales Value Share by Type (2021-2032) Figure 12. Pathological Diagnosis Image Figure 13. Clinical Laboratory Image Figure 14. Drug Discovery Image Figure 15. Others Image Figure 16. Global Digital Pathology Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Digital Pathology Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Digital Pathology Solutions Sales Value Share by Application (2021-2032) Figure 19. Global Digital Pathology Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Digital Pathology Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Digital Pathology Solutions Sales Value (2021-2032) & (US$ Million) Figure 22. North America Digital Pathology Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Digital Pathology Solutions Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Digital Pathology Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Digital Pathology Solutions Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Digital Pathology Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Digital Pathology Solutions Sales Value (2021-2032) & (US$ Million) Figure 28. South America Digital Pathology Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Digital Pathology Solutions Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Digital Pathology Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Digital Pathology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Cytopathology
  • Histopathology
Applications
  • Pathological Diagnosis
  • Clinical Laboratory
  • Drug Discovery
  • Others
Companies covered
  • Roche Diagnostics
  • Proscia
  • 3DHISTECH Ltd.
  • Philips
  • Siemens
  • Morphle Labs Inc
  • TriStar Technology Group
  • Iron Mountain
  • Smart In Media AG
  • HealthTrust Europe
  • Dedalus
  • Tribun Health
  • Qube scientific
  • Leica Biosystems
  • Schneider Electric
  • PathGroup
  • Sectra
  • Gestalt Diagnostics
  • Charles River Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digital Pathology Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digital Pathology Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Digital Pathology Solutions Market Dynamics
  1. 2.1 Digital Pathology Solutions Industry Trends
  2. 2.2 Digital Pathology Solutions Industry Drivers
  3. 2.3 Digital Pathology Solutions Industry Opportunities and Challenges
  4. 2.4 Digital Pathology Solutions Industry Restraints
3 Digital Pathology Solutions Market by Company
  1. 3.1 Global Digital Pathology Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Digital Pathology Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Digital Pathology Solutions Company Ranking (2024-2026)
  4. 3.4 Global Digital Pathology Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global Digital Pathology Solutions Company Product Type and Application
  6. 3.6 Global Digital Pathology Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Digital Pathology Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Digital Pathology Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Digital Pathology Solutions Market by Type
  1. 4.1 Digital Pathology Solutions Type Introduction
  2. 4.1.1 Cytopathology
  3. 4.1.2 Histopathology
  4. 4.2 Global Digital Pathology Solutions Sales Value by Type
  5. 4.2.1 Global Digital Pathology Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Digital Pathology Solutions Sales Value by Type (2021-2032)
  7. 4.2.3 Global Digital Pathology Solutions Sales Value Share by Type (2021-2032)
5 Digital Pathology Solutions Market by Application
  1. 5.1 Digital Pathology Solutions Application Introduction
  2. 5.1.1 Pathological Diagnosis
  3. 5.1.2 Clinical Laboratory
  4. 5.1.3 Drug Discovery
  5. 5.1.4 Others
  6. 5.2 Global Digital Pathology Solutions Sales Value by Application
  7. 5.2.1 Global Digital Pathology Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Digital Pathology Solutions Sales Value by Application (2021-2032)
  9. 5.2.3 Global Digital Pathology Solutions Sales Value Share by Application (2021-2032)
6 Digital Pathology Solutions Regional Value Analysis
  1. 6.1 Global Digital Pathology Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digital Pathology Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Digital Pathology Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Digital Pathology Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digital Pathology Solutions Sales Value (2021-2032)
  7. 6.3.2 North America Digital Pathology Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Digital Pathology Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe Digital Pathology Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Digital Pathology Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Digital Pathology Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Digital Pathology Solutions Sales Value (2021-2032)
  16. 6.6.2 South America Digital Pathology Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Digital Pathology Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Digital Pathology Solutions Sales Value Share by Country, 2025 VS 2032
7 Digital Pathology Solutions Country-level Value Analysis
  1. 7.1 Global Digital Pathology Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digital Pathology Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Digital Pathology Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Digital Pathology Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Digital Pathology Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Digital Pathology Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Digital Pathology Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche Diagnostics
  2. 8.1.1 Roche Diagnostics Company Information
  3. 8.1.2 Roche Diagnostics Business Overview
  4. 8.1.3 Roche Diagnostics Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Diagnostics Digital Pathology Solutions Product Portfolio
  6. 8.1.5 Roche Diagnostics Recent Developments
  7. 8.2 Proscia
  8. 8.2.1 Proscia Company Information
  9. 8.2.2 Proscia Business Overview
  10. 8.2.3 Proscia Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Proscia Digital Pathology Solutions Product Portfolio
  12. 8.2.5 Proscia Recent Developments
  13. 8.3 3DHISTECH Ltd.
  14. 8.3.1 3DHISTECH Ltd. Company Information
  15. 8.3.2 3DHISTECH Ltd. Business Overview
  16. 8.3.3 3DHISTECH Ltd. Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 3DHISTECH Ltd. Digital Pathology Solutions Product Portfolio
  18. 8.3.5 3DHISTECH Ltd. Recent Developments
  19. 8.4 Philips
  20. 8.4.1 Philips Company Information
  21. 8.4.2 Philips Business Overview
  22. 8.4.3 Philips Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Philips Digital Pathology Solutions Product Portfolio
  24. 8.4.5 Philips Recent Developments
  25. 8.5 Siemens
  26. 8.5.1 Siemens Company Information
  27. 8.5.2 Siemens Business Overview
  28. 8.5.3 Siemens Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Siemens Digital Pathology Solutions Product Portfolio
  30. 8.5.5 Siemens Recent Developments
  31. 8.6 Morphle Labs Inc
  32. 8.6.1 Morphle Labs Inc Company Information
  33. 8.6.2 Morphle Labs Inc Business Overview
  34. 8.6.3 Morphle Labs Inc Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Morphle Labs Inc Digital Pathology Solutions Product Portfolio
  36. 8.6.5 Morphle Labs Inc Recent Developments
  37. 8.7 TriStar Technology Group
  38. 8.7.1 TriStar Technology Group Company Information
  39. 8.7.2 TriStar Technology Group Business Overview
  40. 8.7.3 TriStar Technology Group Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 TriStar Technology Group Digital Pathology Solutions Product Portfolio
  42. 8.7.5 TriStar Technology Group Recent Developments
  43. 8.8 Iron Mountain
  44. 8.8.1 Iron Mountain Company Information
  45. 8.8.2 Iron Mountain Business Overview
  46. 8.8.3 Iron Mountain Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Iron Mountain Digital Pathology Solutions Product Portfolio
  48. 8.8.5 Iron Mountain Recent Developments
  49. 8.9 Smart In Media AG
  50. 8.9.1 Smart In Media AG Company Information
  51. 8.9.2 Smart In Media AG Business Overview
  52. 8.9.3 Smart In Media AG Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Smart In Media AG Digital Pathology Solutions Product Portfolio
  54. 8.9.5 Smart In Media AG Recent Developments
  55. 8.10 HealthTrust Europe
  56. 8.10.1 HealthTrust Europe Company Information
  57. 8.10.2 HealthTrust Europe Business Overview
  58. 8.10.3 HealthTrust Europe Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  59. 8.10.4 HealthTrust Europe Digital Pathology Solutions Product Portfolio
  60. 8.10.5 HealthTrust Europe Recent Developments
  61. 8.11 Dedalus
  62. 8.11.1 Dedalus Company Information
  63. 8.11.2 Dedalus Business Overview
  64. 8.11.3 Dedalus Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dedalus Digital Pathology Solutions Product Portfolio
  66. 8.11.5 Dedalus Recent Developments
  67. 8.12 Tribun Health
  68. 8.12.1 Tribun Health Company Information
  69. 8.12.2 Tribun Health Business Overview
  70. 8.12.3 Tribun Health Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Tribun Health Digital Pathology Solutions Product Portfolio
  72. 8.12.5 Tribun Health Recent Developments
  73. 8.13 Qube scientific
  74. 8.13.1 Qube scientific Company Information
  75. 8.13.2 Qube scientific Business Overview
  76. 8.13.3 Qube scientific Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Qube scientific Digital Pathology Solutions Product Portfolio
  78. 8.13.5 Qube scientific Recent Developments
  79. 8.14 Leica Biosystems
  80. 8.14.1 Leica Biosystems Company Information
  81. 8.14.2 Leica Biosystems Business Overview
  82. 8.14.3 Leica Biosystems Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Leica Biosystems Digital Pathology Solutions Product Portfolio
  84. 8.14.5 Leica Biosystems Recent Developments
  85. 8.15 Schneider Electric
  86. 8.15.1 Schneider Electric Company Information
  87. 8.15.2 Schneider Electric Business Overview
  88. 8.15.3 Schneider Electric Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Schneider Electric Digital Pathology Solutions Product Portfolio
  90. 8.15.5 Schneider Electric Recent Developments
  91. 8.16 PathGroup
  92. 8.16.1 PathGroup Company Information
  93. 8.16.2 PathGroup Business Overview
  94. 8.16.3 PathGroup Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  95. 8.16.4 PathGroup Digital Pathology Solutions Product Portfolio
  96. 8.16.5 PathGroup Recent Developments
  97. 8.17 Sectra
  98. 8.17.1 Sectra Company Information
  99. 8.17.2 Sectra Business Overview
  100. 8.17.3 Sectra Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Sectra Digital Pathology Solutions Product Portfolio
  102. 8.17.5 Sectra Recent Developments
  103. 8.18 Gestalt Diagnostics
  104. 8.18.1 Gestalt Diagnostics Company Information
  105. 8.18.2 Gestalt Diagnostics Business Overview
  106. 8.18.3 Gestalt Diagnostics Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Gestalt Diagnostics Digital Pathology Solutions Product Portfolio
  108. 8.18.5 Gestalt Diagnostics Recent Developments
  109. 8.19 Charles River Laboratories
  110. 8.19.1 Charles River Laboratories Company Information
  111. 8.19.2 Charles River Laboratories Business Overview
  112. 8.19.3 Charles River Laboratories Digital Pathology Solutions Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Charles River Laboratories Digital Pathology Solutions Product Portfolio
  114. 8.19.5 Charles River Laboratories Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst